2021
DOI: 10.1002/jcb.30133
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal stem cell and endothelial progenitor cells coinjection improves LPS‐induced lung injury via Tie2 activation and downregulation of the TLR4/MyD88 pathway

Abstract: Sepsis is one of the most important complications of infection with a high mortality rate. Recently, cell therapy has been widely used to reduce the symptoms of sepsis. It has been previously reported that mesenchymal stem cell (MSC) and endothelial progenitor cells (EPC) therapy have beneficial effects in experimental models of sepsis. The effects of coculture of MSC and EPC have not yet been used to treat sepsis. Therefore, the aim of this study was to investigate the therapeutic potential of EPC + MSC cocul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…Its activation in tubular epithelial cells and circulating immune cells leads to the secretion of cytokines that contribute to kidney damage (30). A recent study in mice induced to sepsis and treated with a combination of MSCs and EPCs showed upregulation of proinflammatory factor activation through the TLR4 pathway, together with decreases in the levels of inflammatory cytokines arising from this pathway, such as tumor necrosis factor alpha, interleukin (IL)-1β, and IL-6 (31).…”
Section: Discussionmentioning
confidence: 99%
“…Its activation in tubular epithelial cells and circulating immune cells leads to the secretion of cytokines that contribute to kidney damage (30). A recent study in mice induced to sepsis and treated with a combination of MSCs and EPCs showed upregulation of proinflammatory factor activation through the TLR4 pathway, together with decreases in the levels of inflammatory cytokines arising from this pathway, such as tumor necrosis factor alpha, interleukin (IL)-1β, and IL-6 (31).…”
Section: Discussionmentioning
confidence: 99%